Status:

COMPLETED

Accuracy of Owlet Smart Sock Sensor 3rd Generation With Profound Hypoxia

Lead Sponsor:

Owlet Baby Care, Inc.

Conditions:

Hypoxia

Eligibility:

All Genders

18-49 years

Brief Summary

Performance testing of pulse oximeters. The protocol involves brief stable arterial oxygen desaturation in healthy volunteers and sampling arterial blood when a stable level of hypoxia has been attain...

Eligibility Criteria

Inclusion

  • The subject is male or female, aged ≥18 and \<50.
  • The subject is in good general health with no evidence of any medical problems.
  • The subject is fluent in both written and spoken English.
  • The subject has provided informed consent and is willing to comply with the study procedures.

Exclusion

  • The subject is obese (BMI\>30).
  • The subject has a known history of heart disease, lung disease, kidney or liver disease.
  • Diagnosis of asthma, sleep apnea, or use of CPAP.
  • Subject has diabetes.
  • Subject has a clotting disorder.
  • The subject a hemoglobinopathy or history of anemia, per subject report or the first blood sample, that in the opinion of the investigator, would make them unsuitable for study participation.
  • The subject has any other serious systemic illness.
  • The subject is a current smoker.
  • Any injury, deformity, or abnormality at the sensor sites that in the opinion of the investigators' would interfere with the sensors working correctly.
  • The subject has a history of fainting or vasovagal response.
  • The subject has a history of sensitivity to local anesthesia.
  • The subject has a diagnosis of Raynaud's disease.
  • The subject has unacceptable collateral circulation based on exam by the investigator (Allen's test).
  • The subject is pregnant, lactating or trying to get pregnant.
  • The subject is unable or unwilling to provide informed consent, or is unable or unwilling to comply with study procedures.
  • The subject has any other condition, which in the opinion of the investigators' would make them unsuitable for the study.

Key Trial Info

Start Date :

March 12 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 13 2020

Estimated Enrollment :

14 Patients enrolled

Trial Details

Trial ID

NCT04446247

Start Date

March 12 2020

End Date

March 13 2020

Last Update

October 19 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University California San Fransisco, Department of Anesthesia

San Francisco, California, United States, 94133